Health and QoL in Oncological Patients: Management of Bone Pathology in Italian Citbl Population
- Conditions
- OsteoporosisBreast Cancer Female
- Interventions
- Behavioral: Observational Analysis
- Registration Number
- NCT04055805
- Brief Summary
Studying the current state of the clinical approaches to bone diseases in breast cancer patients treated with adjuvant and/or hormone therapy
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- Female
- Target Recruitment
- 700
- Patients willing to provide the Informed consent to participate to the study
- Women aged 18-75 years
- Patients having breast cancer, with no phenotype restrictions
- Patients in natural and stable menopause
- Patients having secondary amenorrhea, that arose after the initiation of oncologic treatment, since at least 12 months or 6 months with FSH> 40 U/I
- Patients with advanced cancer and/or bone metastases and/or visceral metastases
- Patients with severe renal insufficiency and/or in dialysis and patients affected by severe endocrine disorders
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Fondazione Policlinico Universitario A. Gemelli Roma Observational Analysis U.O.C Chirurgia Senologica Università di Napoli "Federico II" Observational Analysis - Fondazione Policlinico Universitario A. Gemelli, Roma Observational Analysis Polo Scienze della Salute della Donna e del Bambino Università degli Studi di Pavia Observational Analysis - Università degli Studi di Siena Observational Analysis - Azienda Ospedaliero-Universitaria Careggi Firenze Observational Analysis - Istituto Nazionale dei Tumori di Napoli Fondazione G.Pascale Observational Analysis -
- Primary Outcome Measures
Name Time Method Results from some questionnaires related to patients QoL, rated from 1 to 10. 26-32 months Description of the current state of the most frequent clinical and therapeutical approaches to bone diseases in 700 breast cancer menopausal patients treated with adjuvant and/or hormonal therapy. These patients are assessed by questionnaires regarding quality of life, menopausal status and current anti resorptive treatments
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Policlinico Agostino Gemelli
🇮🇹Roma, RM, Italy